RNAV8 Bio
PrivateLast Round
Seed
Mar 17, 2025
Total Funding Raised
$1.01M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RNAV8 Bio operates in Healthcare & Life Sciences and is based in Laguna Niguel, California. Its latest recorded funding round was a Seed round in March 2025.
RNAV8 Bio is a biotechnology company that provides an AI-enabled mRNA engineering platform to optimize coding and non-coding sequences for improved therapeutic outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNAV8 Bio Comparables
Compare RNAV8 Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Raina Biosciences | 89% | |
| Inceptive | 76% | |
| Atomic AI | 66% |
For institutional investors. Book with your work email.
RNAV8 Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
RNAV8 Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Service Provider Capital | Seed |
| Calm Ventures | Seed |
| BioBrit | Seed |
| Portal Innovations | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 218% MoM, from 382 to 1.2K.
For institutional investors. Book with your work email.
RNAV8 Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RNAV8 Bio's valuation, stock price, and market status.
Is RNAV8 Bio a public or private company?
RNAV8 Bio is a private company.
What is the current stock price of RNAV8 Bio?
RNAV8 Bio is a private company, so its shares have no public market price. Caplight tracks RNAV8 Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RNAV8 Bio worth (valuation)?
Valuation information for RNAV8 Bio is not publicly available.
Can I buy RNAV8 Bio stock?
RNAV8 Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RNAV8 Bio's last funding round?
RNAV8 Bio's most recent funding round was Seed on March 17, 2025.
Who are the main investors in RNAV8 Bio?
Key investors in RNAV8 Bio include Service Provider Capital, Calm Ventures, BioBrit, Portal Innovations.
Will RNAV8 Bio IPO soon?
No public IPO plans have been announced for RNAV8 Bio.
How can I track RNAV8 Bio secondary market activity?
Caplight tracks bids, offers, and trades in RNAV8 Bio's shares on secondary markets.